SE8102456L - Farmaceutisk komposition for oral administering och innehallande cytidindifosfokolin - Google Patents

Farmaceutisk komposition for oral administering och innehallande cytidindifosfokolin

Info

Publication number
SE8102456L
SE8102456L SE8102456A SE8102456A SE8102456L SE 8102456 L SE8102456 L SE 8102456L SE 8102456 A SE8102456 A SE 8102456A SE 8102456 A SE8102456 A SE 8102456A SE 8102456 L SE8102456 L SE 8102456L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
oral administration
diphosphocoline
containing cytidine
cytidine
Prior art date
Application number
SE8102456A
Other languages
English (en)
Other versions
SE447449B (sv
Inventor
E Borgo
Original Assignee
Made Italiana Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana Srl filed Critical Made Italiana Srl
Publication of SE8102456L publication Critical patent/SE8102456L/sv
Publication of SE447449B publication Critical patent/SE447449B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8102456A 1980-04-18 1981-04-15 Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider SE447449B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (2)

Publication Number Publication Date
SE8102456L true SE8102456L (sv) 1981-10-19
SE447449B SE447449B (sv) 1986-11-17

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8102456A SE447449B (sv) 1980-04-18 1981-04-15 Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider

Country Status (15)

Country Link
US (1) US4386077A (sv)
AT (1) AT376366B (sv)
AU (1) AU544469B2 (sv)
BE (1) BE890796A (sv)
CH (1) CH652026A5 (sv)
DE (1) DE3115080C2 (sv)
DK (1) DK173081A (sv)
ES (1) ES502080A0 (sv)
FR (1) FR2480603B1 (sv)
GB (1) GB2074445B (sv)
IN (1) IN156105B (sv)
IT (1) IT1207106B (sv)
NL (1) NL8101899A (sv)
SE (1) SE447449B (sv)
ZA (1) ZA812600B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (en) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. New pharmaceutical composition
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
EP0566135A1 (en) * 1992-04-17 1993-10-20 Takeda Chemical Industries, Ltd. Transmucosal composition comprising a peptide and a cytidine derivative
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
CN1126546C (zh) * 1995-03-06 2003-11-05 英特纽隆制剂药有限公司 使用胞磷胆碱减少梗塞面积
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
WO2001068104A1 (en) * 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
CA2517290A1 (en) * 2003-02-26 2004-09-10 Kyowa Hakko Kogyo Co., Ltd. Muscle-building agent and preventive or remedy for muscle weakening
US20090215714A1 (en) * 2004-06-10 2009-08-27 Perry Renshaw Pyrimidines, such as cytidine, in treatments for patients with biopolar disorder
US7737128B2 (en) * 2004-06-10 2010-06-15 The Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
WO2006020703A1 (en) * 2004-08-11 2006-02-23 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1189549A (en) * 1967-12-18 1970-04-29 Takeda Chemical Industries Ltd A Method for Production of Cytidine (Deoxycytidine)-5'-Diphosphate Choline and Intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (sv) * 1969-08-04 1973-12-07
JPS4886869A (sv) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
ATA172081A (de) 1984-04-15
GB2074445B (en) 1983-09-07
FR2480603B1 (fr) 1985-07-12
DE3115080C2 (de) 1986-10-16
IT1207106B (it) 1989-05-17
IN156105B (sv) 1985-05-18
AU6994581A (en) 1981-10-22
SE447449B (sv) 1986-11-17
FR2480603A1 (fr) 1981-10-23
DE3115080A1 (de) 1982-02-25
ES8207184A1 (es) 1982-09-01
IT8048454A0 (it) 1980-04-18
DK173081A (da) 1981-10-19
ZA812600B (en) 1982-04-28
NL8101899A (nl) 1981-11-16
GB2074445A (en) 1981-11-04
US4386077A (en) 1983-05-31
ES502080A0 (es) 1982-09-01
BE890796A (fr) 1982-02-15
CH652026A5 (it) 1985-10-31
AU544469B2 (en) 1985-05-30
AT376366B (de) 1984-11-12

Similar Documents

Publication Publication Date Title
IE862554L (en) Pharmaceutical compositions
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
SE8102456L (sv) Farmaceutisk komposition for oral administering och innehallande cytidindifosfokolin
MC1418A1 (fr) 2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances
SE8402560L (sv) Farmaceutisk komposition
MX9203114A (es) Nuevos derivados morfolino de daunorubicina y doxorubicina y composiciones farmaceuticas que los contienen.
DE3768419D1 (de) Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
FI810380L (fi) Fenylpiperazinderivat av 1,3,4-oxadiazolylfenoler deras framstaellning och dessa innehaollande terapeutiska aemnen
FI832072A0 (fi) 1,4-dihydropyridiner i optiskt aktiv eller racematform, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
BE888525A (fr) Nucleoside de la classe des desazapurines, compositions en contenant et leur application en medecine,
ATA133288A (de) Pharmazeutische zusammensetzung
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
FR2496658B1 (fr) Derives de l'acide nicotinique, leur preparation et medicament contenant ces substances
SE448090B (sv) Tiokarnitiner och farmaceutiska kompositioner som innehaller dessa
BE881799A (fr) Analogues de la protaglandine i2 et compositions pharmaceutiques les contenant
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
IT8249521A0 (it) Composizioni farmaceutiche contenenti idrossicicloesilammine da usare nel trattamento di malattie respiratorie
FI793039A (fi) Oktahydro-1h-benso(4,5)-furo(3,2-e)-isokinoliner med analgetiska och narkotikaantagonistiska egenskaper
DE3667915D1 (de) Pharmazeutische zusammensetzung.
DK606583D0 (da) Farmaceutiske formuleringer med cytostatisk virkning

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8102456-4

Effective date: 19910117

Format of ref document f/p: F